CD8A and neoplasm: cDC1s not only take up and cross-present tumor antigens via major histocompatibility complex (MHC) class I to activate naive CD8+ T cells; but also support the cytotoxicity of CD8+ T cells by secreting large amounts of interleukin-12 (IL-12).